CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Other loans, including deposit overdrafts [Member]	Other loans, including deposit overdrafts [Member] OAEM [Member]	Common Stock [Member]	Common Stock [Member] Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings [Member] Accounting Standards Update 2016-13	Treasury Stock, Common	Treasury Stock, Common Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income [Member]	Accumulated Other Comprehensive Income [Member] Cumulative Effect, Period of Adoption, Adjustment
Balance Beginning (in shares) at Dec. 31, 2021					12,414,956
Balance beginning at Dec. 31, 2021	$ 238,604				$ 143,130		$ 126,312			$ (29,029)		$ (1,809)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,523						4,523
Other comprehensive income, net of taxes	(13,188)											(13,188)
Dividend Reinvestment and Stock Purchase Plan (in shares)					5,681
Dividend Reinvestment and Stock Purchase Plan	105				$ 105
Compensation expense relating to restricted stock (in shares)					32,554
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition	197				$ 197
Dividends, Common Stock, Cash	(2,280)						(2,280)
Treasury shares purchased (in shares)					(1,051,688)
Repurchase of common stock	(21,086)									(21,086)
Balance Ending (in shares) at Mar. 31, 2022					11,401,503
Balance ending at Mar. 31, 2022	$ 206,875				$ 143,432		128,555			(50,115)		(14,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per common share (usd per share)	$ 0.20
Financing Receivable, Revolving, Converted to Term Loan	$ 6,056		$ 0	$ 0
Balance Beginning (in shares) at Dec. 31, 2022	11,259,080				11,259,080	11,259,080
Balance beginning at Dec. 31, 2022	$ 200,675	$ 198,753			$ 144,069	$ 144,069	139,249	$ 137,327	$ (1,922)	(52,689)	$ (52,689)	(29,954)	$ (29,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,157						4,157
Other comprehensive income, net of taxes	4,950											4,950
Dividend Reinvestment and Stock Purchase Plan (in shares)					5,861
Dividend Reinvestment and Stock Purchase Plan	103				$ 103
Compensation expense relating to restricted stock (in shares)					44,150
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition	316				$ 316
Dividends, Common Stock, Cash	(2,369)						(2,369)
Treasury shares purchased (in shares)					(107,028)
Repurchase of common stock	$ (1,838)									(1,838)
Balance Ending (in shares) at Mar. 31, 2023	11,202,063				11,202,063
Balance ending at Mar. 31, 2023	$ 204,072				$ 144,488		$ 139,115			$ (54,527)		$ (25,004)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, Other	$ (1,922)
Dividends declared per common share (usd per share)	$ 0.21
Financing Receivable, Revolving, Converted to Term Loan	$ 1,507		$ 0	$ 0